Bramlage P - Search Results

1

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

Riess H, Pelzer U, Hilbig A, Stieler J, Opitz B, Scholten T, Kauschat-Brüning D, Bramlage P, Dörken B, Oettle H. Riess H, et al. Among authors: bramlage p. BMC Cancer. 2008 Dec 5;8:361. doi: 10.1186/1471-2407-8-361. BMC Cancer. 2008. PMID: 19055847 Free PMC article. Clinical Trial.

2

Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.

Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H. Haas S, et al. Among authors: bramlage p. BMC Cancer. 2011 Jul 26;11:316. doi: 10.1186/1471-2407-11-316. BMC Cancer. 2011. PMID: 21791091 Free PMC article. Clinical Trial.

3

An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.

Schellong SM, Haas S, Greinacher A, Schwanebeck U, Sieder C, Abletshauser C, Bramlage P, Riess H. Schellong SM, et al. Among authors: bramlage p. Expert Opin Pharmacother. 2010 Dec;11(18):2953-61. doi: 10.1517/14656566.2010.521498. Epub 2010 Oct 18. Expert Opin Pharmacother. 2010. PMID: 20950224 Clinical Trial.

4

Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study.

Tebbe U, Schellong SM, Haas S, Gerlach HE, Abletshauser C, Sieder C, Bramlage P, Riess H. Tebbe U, et al. Among authors: bramlage p. Am Heart J. 2011 Feb;161(2):322-8. doi: 10.1016/j.ahj.2010.10.005. Am Heart J. 2011. PMID: 21315215 Clinical Trial.

5

[Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation].

Helms TM, Gulba D, Ahrens I, Schäfer A, Hankowitz J, Kuhlencordt P, Lipp HP, Nikol S, Riess H, Stargardt T, Bramlage P. Helms TM, et al. Among authors: bramlage p. Dtsch Med Wochenschr. 2017 Jul;142(13):986-993. doi: 10.1055/s-0042-124132. Epub 2017 Apr 19. Dtsch Med Wochenschr. 2017. PMID: 28423431 Review. German.

6

First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.

Zidek W, Schrader J, Lüders S, Matthaei S, Hasslacher C, Hoyer J, Bramlage P, Sturm CD, Paar WD. Zidek W, et al. Among authors: bramlage p. Cardiovasc Diabetol. 2008 Jul 24;7:22. doi: 10.1186/1475-2840-7-22. Cardiovasc Diabetol. 2008. PMID: 18652658 Free PMC article. Clinical Trial.

7

Prevention of venous thromboembolism using enoxaparin in day surgery: results of the SMART noninterventional study.

Haas S, Hohmann V, Bramlage P. Haas S, et al. Among authors: bramlage p. Clin Appl Thromb Hemost. 2012 Jun;18(3):265-71. doi: 10.1177/1076029611425379. Epub 2011 Nov 14. Clin Appl Thromb Hemost. 2012. PMID: 22084412 Free article. Clinical Trial.

8

Benefits and risks of preventing thromboembolism with enoxaparin in patients with general surgery in real world--the CLEVER study.

Schellong SM, Encke A, Weber AA, Bramlage P, Paar WD, Haas S. Schellong SM, et al. Among authors: bramlage p. Clin Appl Thromb Hemost. 2013 Jun;19(3):282-8. doi: 10.1177/1076029612461067. Epub 2012 Oct 11. Clin Appl Thromb Hemost. 2013. PMID: 23064219 Free article.

9

The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.

Bauersachs R, Agnelli G, Gitt AK, Monreal M, Mismetti P, Willich SN, Laeis P, Fronk EM, Bramlage P, Cohen AT; PREFER in VTE Scientific Steering Committee. Bauersachs R, et al. Among authors: bramlage p. Thromb Res. 2017 Sep;157:181-188. doi: 10.1016/j.thromres.2017.07.029. Epub 2017 Jul 28. Thromb Res. 2017. PMID: 28780343

10

ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries.

Cohen AT, Hoffmann U, Hainaut P, Gaine S, Ay C, Coppens M, Schindewolf M, Jimenez D, Brüggenjürgen B, Levy P, Laeis P, Fronk EM, Zierhut W, Malzer T, Manu MC, Reimitz PE, Bramlage P, Agnelli G; ETNA-VTE-Europe investigators. Cohen AT, et al. Among authors: bramlage p. Eur J Intern Med. 2020 Dec;82:48-55. doi: 10.1016/j.ejim.2020.08.014. Epub 2020 Aug 18. Eur J Intern Med. 2020. PMID: 32826158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters